{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:09:49Z","timestamp":1793725789099,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004118"],"award-info":[{"award-number":["82004118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["Z2020015"],"award-info":[{"award-number":["Z2020015"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["NZY82004118"],"award-info":[{"award-number":["NZY82004118"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["NJSYXZDSYS-2023"],"award-info":[{"award-number":["NJSYXZDSYS-2023"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["XZR2023059"],"award-info":[{"award-number":["XZR2023059"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbadis.2026.168313","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:41:20Z","timestamp":1780501280000},"page":"168313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Huaier counteracts sorafenib resistance in hepatocellular carcinoma by activating NCOA4-mediated ferritinophagy to induce ferroptosis via modulation of iron and lipid metabolism"],"prefix":"10.1016","volume":"1872","author":[{"given":"Zhengguang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168313_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4254\/wjh.v15.i4.460","article-title":"Recent advances in recurrent hepatocellular carcinoma therapy","volume":"15","author":"Gao","year":"2023","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168313_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.21037\/jgo-23-45","article-title":"Imaging findings of hepatocellular carcinoma with portal vein tumor thrombosis secondary to hepatic portal vein collateral circulation: a cross-sectional study","volume":"14","author":"Shi","year":"2023","journal-title":"J Gastrointest Oncol."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168313_bb0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168313_bb0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/RLI.0000000000001100","article-title":"Local Ablation Therapy for Hepatocellular Carcinoma: Clinical Significance of Tumor Size, Location, and Biology","volume":"60","author":"Lee","year":"2025","journal-title":"Investig. Radiol."},{"issue":"16","key":"10.1016\/j.bbadis.2026.168313_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162656","article-title":"Clinical and imaging-based prognostic models for recurrence and local tumor progression following thermal ablation of hepatocellular carcinoma: a systematic review","volume":"17","author":"Verhagen","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168313_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.14740\/wjon2571","article-title":"Immune Checkpoint Inhibition for Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular-Cholangiocarcinoma","volume":"16","author":"Shichiri","year":"2025","journal-title":"World. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188841","article-title":"Lenvatinib plus immune checkpoint inhibitors or locoregional therapy in unresectable hepatocellular carcinoma: Lessons learned and moving forwards","volume":"1878","author":"Wang","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168313_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104765","article-title":"Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects","volume":"212","author":"Yousef","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188382","article-title":"New insights on sorafenib resistance in liver cancer with correlation of individualized therapy","volume":"1874","author":"Cheng","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168313_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189310","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168313_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189334","article-title":"PD-1\/PD-L1 blockade therapy in hepatocellular carcinoma: Current status and potential biomarkers","volume":"1880","author":"Xu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168313_bb0085","doi-asserted-by":"crossref","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","article-title":"PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0090","first-page":"410","article-title":"Ferritinophagy: research advance and clinical significance in cancers[J]","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168313_bb0095","doi-asserted-by":"crossref","first-page":"1043344","DOI":"10.3389\/fphar.2022.1043344","article-title":"Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168313_bb0100","doi-asserted-by":"crossref","first-page":"1551003","DOI":"10.3389\/fcell.2025.1551003","article-title":"Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases","volume":"13","author":"Wu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168313_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188917","article-title":"A novel view of ferritin in cancer","volume":"1878","author":"Shesh","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168313_bb0110","series-title":"The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis","first-page":"41","author":"Santana-Codina","year":"2021"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41419-025-07772-0","article-title":"Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis","volume":"16","author":"Ye","year":"2025","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168313_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11912-023-01408-2","article-title":"Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies","volume":"25","author":"Narayanan","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbadis.2026.168313_bb0125","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.2147\/OTT.S279723","article-title":"Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins","volume":"13","author":"Niu","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbadis.2026.168313_bb0130","article-title":"Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168313_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ph18060884","article-title":"The efficacy of combined use of Huaier granules in the treatment of primary liver cancer: an updated systematic review and meta-analysis","volume":"18","author":"Zhou","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168313_bb0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.21037\/tcr-23-1347","article-title":"Huaier granule improves liver inflammation and fibrosis and prevents recurrence in hepatitis B virus related hepatocellular carcinoma","volume":"13","author":"Wu","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"19","key":"10.1016\/j.bbadis.2026.168313_bb0145","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.7150\/jca.21018","article-title":"Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1","volume":"8","author":"Shan","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168313_bb0150","doi-asserted-by":"crossref","first-page":"1269096","DOI":"10.3389\/fphar.2023.1269096","article-title":"Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment[J]","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CM9.0000000000002966","article-title":"Effect of Huaier granule on prognosis of breast cancer: A single-center propensity score matching retrospective study","volume":"138","author":"Guo","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbadis.2026.168313_bb0160","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fonc.2019.01195","article-title":"Huaier Suppresses Breast Cancer Progression via linc00339\/miR-4656\/CSNK2B Signaling Pathway","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168313_bb0165","doi-asserted-by":"crossref","first-page":"6065516","DOI":"10.1155\/2022\/6065516","article-title":"Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation[J]","volume":"2022","author":"Shi","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168313_bb0170","first-page":"1","article-title":"GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier[J]","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168313_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7150\/ijms.89308","article-title":"Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2\/miR-212-5p\/ELF3 axis","volume":"21","author":"Wu","year":"2024","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168313_bb0180","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/jcmm.16215","article-title":"Huaier shows anti-cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K\/AKT\/HIF-1alpha pathway","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0185","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8840","article-title":"Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt\/\u03b2\u2011catenin signaling pathway","volume":"53","author":"Huo","year":"2025","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168313_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12032-022-01797-7","article-title":"The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death","volume":"39","author":"Zhang","year":"2022","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168313_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41420-025-02598-3","article-title":"Huaier suppresses lung cancer by simultaneously and independently inhibiting the antioxidant pathway SLC7A11\/GPX4 while enhancing ferritinophagy","volume":"11","author":"Shi","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbadis.2026.168313_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152348","article-title":"Targeting STAT3 by erianin to overcome sorafenib resistance in hepatocellular carcinoma: Integrated network pharmacology with molecular docking, dynamics simulations, and in vitro validation","volume":"778","author":"Liu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168313_bb0205","first-page":"386","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbadis.2026.168313_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101084","article-title":"Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma","volume":"74","author":"Zhao","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbadis.2026.168313_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118578","article-title":"The role and molecular mechanism of Trametes Robiniophila Murr(Huaier) in tumor therapy","volume":"334","author":"Ji","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168313_bb0220","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/hep4.2040","article-title":"Co-regulation of hepatic steatosis by ferritinophagy and unsaturated fatty acid supply","volume":"6","author":"Li","year":"2022","journal-title":"Hepatol. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:25:41Z","timestamp":1783412741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926001766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0925443926001766"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168313","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huaier counteracts sorafenib resistance in hepatocellular carcinoma by activating NCOA4-mediated ferritinophagy to induce ferroptosis via modulation of iron and lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168313"}}